Trimetazidine in geriatric patients with stable angina pectoris: the tiger study.

@article{Klbel2003TrimetazidineIG,
  title={Trimetazidine in geriatric patients with stable angina pectoris: the tiger study.},
  author={F K{\"o}lbel and V Băda},
  journal={International journal of clinical practice},
  year={2003},
  volume={57 10},
  pages={867-70}
}
This study aims to assess the efficacy and tolerance of the metabolic antianginal agent trimetazidine, a 3-KAT inhibitor, in 141 stable angina patients aged 65-86 years. Efficacy was assessed with exercise tests and clinical evaluation after 12 weeks of treatment. The main outcome was an increase in exercise duration by 52 +/- 92 sec (p < 0.001). Other exercise test parameters also improved, with no change in rate-pressure product. Angina attacks and short-acting nitrate consumption… CONTINUE READING